Becton Dickinson & Co (NYSE: BDX) kicked off on Monday, down -0.54% from the previous trading day, before settling in for the closing price of $173.45. Over the past 52 weeks, BDX has traded in a range of $163.33-$251.99.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 4.47%. While this was happening, its average annual earnings per share was recorded 7.98%. With a float of $286.05 million, this company’s outstanding shares have now reached $286.61 million.
Let’s determine the extent of company efficiency that accounts for 74000 employees. In terms of profitability, gross margin is 44.5%, operating margin of 11.33%, and the pretax margin is 8.07%.
Becton Dickinson & Co (BDX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Becton Dickinson & Co is 0.19%, while institutional ownership is 92.40%. The most recent insider transaction that took place on Jun 02 ’25, was worth 199,608. In this transaction EVP and Chief ISC Officer of this company sold 1,166 shares at a rate of $171.19, taking the stock ownership to the 4,575 shares. Before that another transaction happened on Jun 02 ’25, when Company’s Officer proposed sale 1,166 for $172.59, making the entire transaction worth $201,240.
Becton Dickinson & Co (BDX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 3.99 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.98% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.07% during the next five years compared to 8.27% growth over the previous five years of trading.
Becton Dickinson & Co (NYSE: BDX) Trading Performance Indicators
Take a look at Becton Dickinson & Co’s (BDX) current performance indicators. Last quarter, stock had a quick ratio of 0.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.37. Likewise, its price to free cash flow for the trailing twelve months is 19.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.24, a number that is poised to hit 3.42 in the next quarter and is forecasted to reach 14.65 in one year’s time.
Technical Analysis of Becton Dickinson & Co (BDX)
Looking closely at Becton Dickinson & Co (NYSE: BDX), its last 5-days average volume was 2.57 million, which is a jump from its year-to-date volume of 2.55 million. As of the previous 9 days, the stock’s Stochastic %D was 51.74%. Additionally, its Average True Range was 4.01.
During the past 100 days, Becton Dickinson & Co’s (BDX) raw stochastic average was set at 10.35%, which indicates a significant decrease from 49.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.52% in the past 14 days, which was lower than the 41.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $188.44, while its 200-day Moving Average is $221.40.
